Archives

Losing weight but gaining weakness? What Ozempic might be doing to your muscles​Losing weight but gaining weakness? What Ozempic might be doing to your muscles 

Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This raises significant concerns for older adults, who are already at risk for muscle loss and reduced mobility. Researchers stress the urgent need for human clinical trials to understand these effects fully. ​Ozempic’s weight loss benefits Read More

Losing weight but gaining weakness? What Ozempic might be doing to your muscles​Losing weight but gaining weakness? What Ozempic might be doing to your muscles 

Ozempic’s weight loss benefits might come at the cost of muscle strength, even if muscle size remains relatively stable. This raises significant concerns for older adults, who are already at risk for muscle loss and reduced mobility. Researchers stress the urgent need for human clinical trials to understand these effects fully. ​Ozempic’s weight loss benefits Read More

Fat melts away, but so does muscle: What Ozempic users need to know​Fat melts away, but so does muscle: What Ozempic users need to know 

GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they’re not improving a critical measure of health: cardiorespiratory fitness. While these medications help people shed fat, they also strip away vital muscle mass raising concerns about long-term heart health, physical function, and mortality. The researchers urge combining treatment with exercise, Read More

Fat melts away, but so does muscle: What Ozempic users need to know​Fat melts away, but so does muscle: What Ozempic users need to know 

GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they’re not improving a critical measure of health: cardiorespiratory fitness. While these medications help people shed fat, they also strip away vital muscle mass raising concerns about long-term heart health, physical function, and mortality. The researchers urge combining treatment with exercise, Read More

Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle​Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle 

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have shown significant effectiveness in both lowering blood sugar levels and aiding weight loss due to their unique pharmacological mechanisms. A research team assessed the impact of Read More

Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle​Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle 

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have shown significant effectiveness in both lowering blood sugar levels and aiding weight loss due to their unique pharmacological mechanisms. A research team assessed the impact of […]